Clinical application of positron emission tomography - Six month's experience;Klinicke vyuziti pozitronove emisni tomografie - Pulrocni zkusenosti

Prakticky Lekar

Volumn 80, Issue 9, 2000, Pages 503-506

  Belohlavek, O ^a   Taborska, K ^a   Simonova, K ^a   Janeba, D ^a  

^a Oddeleni Nuklearni Mediciny   (Czech Republic)

Author keywords

Diagnostics; Imaging methods; Nuclear medicine; Positron emission temography

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; CARDIOLOGY; COST CONTROL; CZECH REPUBLIC; DIAGNOSTIC IMAGING; EXPERIENCE; HEALTH CARE COST; IMAGING SYSTEM; NEUROLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLOGY; POSITRON EMISSION TOMOGRAPHY; WHOLE BODY SCINTISCANNING;

EID: 0034714806     PISSN: 00326739     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Does positron emission tomography using 18-fluoro-2-deoxyglucose improve clinical staging of testicular cancer? Results of a study in 50 patients
2. F-18 fluoro-deoxyglucose (FDG) and C-reactive protein (CRP)
3. Positron emission tomography scans in the evaluation of postchemotherapy residual masses in patients with seminoma
4. A window on Japan: Medical health club with clinical PET
5. The role of PET-FDG in children with Hodgkin's and non Hodgkin's lymphoma at stop therapy
6. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine
7. Prospective investigation of positron emission tomography in lung nodules
8. PET radio-pharmaceuticals in Europe: Current use and data relevant for the formulation of summaries of product characteristics (SPCs)
9. Differentiating recurrent tumor from radiation necrosis: Time for revaluation of positron emission tomography?
10. Cost effectiveness of PET in oncology
11. Impact of nuclear cardiac imaging on the present and future practice of cardiology
12. Adaptive, Segmented Attenuation Correction for Whole-Body PET Imaging